Clinical Trial Update: Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the frequency of hypoglycemic episodes in well-controlled Type 1 diabetes patients treated with insulin detemir has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED